Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 1,145.70
-16.30 (-1.40%)
Oct 1, 2026, 3:15 PM IST
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 1.14 trillion as of October 1, 2026. Its market cap has increased by 15.67% in one year.
Market Cap
1.14T
Enterprise Value
1.24T
Revenue
285.92B
Ranking
n/a
PE Ratio
25.54
Stock Price
1,145.70
ChartMarket Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 1.14T, an increase of 13,844.24%. That is a compound annual growth rate of 22.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 1.14T | 24.22% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.46T |
| Cipla | 1.09T |
| Laurus Labs | 1.07T |
| Mankind Pharma | 1.05T |
| Aurobindo Pharma | 964.79B |
| Glenmark Pharmaceuticals | 657.81B |
| Alkem Laboratories | 624.13B |
| Ipca Laboratories | 493.00B |